STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[SCHEDULE 13G] HilleVax, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person: Percentage calculated based on 50,141,064 shares of Common Stock outstanding on May 5, 2025, as reported in the Form 10-Q filed by the Issuer for the quarter ended March 31, 2025.


SCHEDULE 13G




Comment for Type of Reporting Person: Percentage calculated based on 50,141,064 shares of Common Stock outstanding on May 5, 2025, as reported in the Form 10-Q filed by the Issuer for the quarter ended March 31, 2025.


SCHEDULE 13G




Comment for Type of Reporting Person: Percentage calculated based on 50,141,064 shares of Common Stock outstanding on May 5, 2025, as reported in the Form 10-Q filed by the Issuer for the quarter ended March 31, 2025.


SCHEDULE 13G



EcoR1 Capital, LLC
Signature:/s/ Oleg Nodelman
Name/Title:Manager
Date:07/24/2025
Oleg Nodelman
Signature:/s/ Oleg Nodelman
Name/Title:Reporting person
Date:07/24/2025
EcoR1 Capital Fund Qualified, L.P.
Signature:/s/ Oleg Nodelman
Name/Title:Manager of the General Partner, EcoR1 Capital, LLC
Date:07/24/2025
Exhibit Information

EXHIBIT 99.1 - AGREEMENT REGARDING JOINT FILING OF STATEMENT ON SCHEDULE 13D OR 13G

HilleVax, Inc.

NASDAQ:HLVX

HLVX Rankings

HLVX Latest News

HLVX Latest SEC Filings

HLVX Stock Data

104.76M
30.11M
17.09%
70.43%
0.71%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States
BOSTON